Determination of ctDNA, Targeted Therapies and Immunotherapy in Non-small-cell Lung Cancer| Chapter 12 | Issues and Development in Health Research Vol. 2
NSCLC, a kind of lung cancer, is one of the
top causes of cancer death in both men and women around the world. From
diagnostics to targeted NSCLC therapies, circulating tumour DNA (ctDNA),
tyrosine kinase inhibitors (TKIs), and immunotherapy have revolutionised our
understanding of NSCLC and its treatment. Quantifying ctDNA is simple and
accurate, which makes clinical decisions easier. TKI-based targeted therapy and
immunotherapy have also improved NSCLC patients' quality of life. This article
provides an overview of ctDNA technologies and their therapeutic applications.
including TKIs such as osimertinib and lorlatinib that target the epidermal
growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK), the
emergence of various resistance mechanisms, the control of programmed cell
death-1 (PD-1) and programmed cell death ligand-1 (PD-L1) and cytotoxic
T-lymphocyte antigen-4 (CTLA-4) by immune checkpoint inhibitors (ICIs) in
Patients with NSCLC, on the other hand, have numerous challenges. More research
and trials are needed to develop more effective drugs or therapies to treat
NSCLC.
Author
(S) Details
Chennianci Zhu
Zhejiang
Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of
Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018,
China.
Weihao Zhuang
Zhejiang
Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of
Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018,
China.
Limin Chen
Zhejiang
Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of
Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018,
China.
Wenyu Yang
Zhejiang
Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of
Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018,
China.
Wen-Bin Ou
Zhejiang
Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of
Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018,
China.
View Book :- https://stm.bookpi.org/IDHR-V2/article/view/3090
Comments
Post a Comment